-
-
-
-
-
-
-
Theralase(R) Closes $CAN 2.66 Million Financing
-
-
-
-
-
-
-
Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
-
-
-
-
-
-
-
Theralase launches $2 million private placement, ends brokered financing
-
-
-
-
-
-
-
Theralase(R) Extends Warrants
-
-
-
-
-
-
-
Theralase(R) 1Q2025 Financial Statements
-
-
-
-
-
-
-
Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
-
-
-
-
-
-
-
CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes
-
414,237 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

